Advanced search
Start date
Betweenand

Synthesis and pharmacological evaluation of new pomalidomide derivatives to treat sickle cell disease symptoms

Grant number: 14/06755-6
Support type:Scholarships in Brazil - Doctorate
Effective date (Start): August 01, 2014
Effective date (End): February 07, 2018
Field of knowledge:Health Sciences - Pharmacy
Cooperation agreement: Coordination of Improvement of Higher Education Personnel (CAPES)
Principal Investigator:Jean Leandro dos Santos
Grantee:Thaís Regina Ferreira de Melo
Home Institution: Faculdade de Ciências Farmacêuticas (FCFAR). Universidade Estadual Paulista (UNESP). Campus de Araraquara. Araraquara , SP, Brazil
Associated scholarship(s):16/11283-1 - Study of gamma globin gene expression induced by pomalidomide derivatives, BE.EP.DR

Abstract

The Sickle Cell Anemia (SCD) is a genetic blood disease characterized by a mutation in the ² -hemoglobin gene. This mutation promotes polymerization of hemoglobin molecules, in situations of low oxygen tension, which alter the structure of the erythrocyte cytoskeleton promoting changes in its physical structure (sickling). Furthermore, there is an increased adhesion of cells to the blood vessel promoting vaso-occlusive process, the main characteristic of the disease. The disease promotes chronic inflammation and increase several proinflammatory cytokines, such as TNF-alpha, this is therefore an important target for therapeutic intervention. Currently, hydroxyurea (HU) is the only drug available for the treatment and its beneficial effects are associated with nitric oxide (NO) released after metabolism. Nitric oxide (NO) plays beneficial effects such as vasodilation, inhibition of platelet aggregation and the production of fetal hemoglobin (HbF). HbF reduces the polymerization of hemoglobin S (HbS) and assists in transporting oxygen from the patient with disease. In our previous studies we found that the strategy of inhibition of TNF- ± associated with the NO release is an important approach for the treatment of symptoms associated with sickle cell disease, such molecules are capable of inducing the synthesis of HbF, inhibiting platelet aggregation and also reducing pain and inflammation associated with the disease. Thus, intending to optimize the activity of precursor molecules, this project proposes the synthesis and evaluation of a new series of hybrid molecules (3a-c and 4a- f) containing an inhibitory subunit of TNF-±, derived from pomalidomida, associated with furoxan derivatives with higher NO release profile in accordance with the structural engineering (Scheme 1) in order to characterize the best drug candidates for the treatment of symptoms of sickle cell disease. (AU)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
FERREIRA DE MELO, THAIS REGINA; KUMKHAEK, CHUTIMA; DOS SANTOS FERNANDES, GUILHERME FELIPE; LOPES PIRES, MARIA ELISA; CHELUCCI, RAFAEL CONSOLIN; BARBIERI, KARINA PEREIRA; COELHO, FERNANDA; DE OLIVEIRA CAPOTE, TICIANA SIDORENKO; LANARO, CAROLINA; CARLOS, IRACILDA ZEPPONE; MARCONDES, SISI; CHEGAEV, KONSTANTIN; GUGLIELMO, STEFANO; FRUTTERO, ROBERTA; CHUNG, MAN CHIN; COSTA, FERNANDO FERREIRA; RODGERS, GRIFFIN P.; DOS SANTOS, JEAN LEANDRO. Discovery of phenylsulfonylfuroxan derivatives as gamma globin inducers by histone acetylation. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v. 154, p. 341-353, JUN 25 2018. Web of Science Citations: 0.
JORNADA, DANIELA HARTMANN; DOS SANTOS FERNANDES, GUILHERME FELIPE; CHIBA, DIEGO EIDY; FERREIRA DE MELO, THAIS REGINA; DOS SANTOS, JEAN LEANDRO; CHUNG, MAN CHIN. The Prodrug Approach: A Successful Tool for Improving Drug Solubility. Molecules, v. 21, n. 1 JAN 2016. Web of Science Citations: 40.
Academic Publications
(References retrieved automatically from State of São Paulo Research Institutions)
MELO, Thaís Regina Ferreira de. Síntese e avaliação farmacológica de novos derivados da pomalidomida para o tratamento da anemia falciforme. 2018. 152 f. Doctoral Thesis - Universidade Estadual Paulista "Júlio de Mesquita Filho" Faculdade de Ciências Farmacêuticas..

Please report errors in scientific publications list by writing to: cdi@fapesp.br.